CONTRA-MAB

Welcome to the Brand page for “CONTRA-MAB”, which is offered here for Genetically engineered proteins for diagnostic purposes; gene therapy and proteins, antibodies and fusion proteins for the treatment of cancer; pharmaceutical substances and preparations namely, genetically engineered proteins for medical diagnostic use; pharmaceutical and biochemical preparations for the treatment of cancer; biochemicals, engineered proteins for the regulation of human, animal, plant, viral and microbial genes for clinical and medical laboratory use in human and animal therapeutics for the treatment of cancer, dna diagnostics and bioinformatics for medical diagnostic purposes;.

Its status is currently believed to be active. Its class is unavailable. “CONTRA-MAB” is believed to be currently owned by “INHIBRX, INC.”